Powered by
Editas Medicine to Present at Investor Conferences in March

CAMBRIDGE, Mass., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in March.  Details of the presentations are as follows:

Live webcasts of the presentations will be available on the Investors & Media section of the Editas website at www.editasmedicine.com.  Archived replays will be available for approximately 30 days following the respective pre

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox